Inventor

Hank F. Kung

Inventor
Wynnewood, PA, US

Overview

43→
Patents
1982–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 43 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
C07DHeterocyclic compounds22%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations13%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium13%
C07BGeneral methods of organic chemistry10%
C07CAcyclic or carbocyclic compounds10%
A61BDiagnosis2%
C07KPeptides1%
PatentTitleYear
11,071,794Deuterium substituted positron emission tomography (PET) imaging agents and their pharmacological application202110,912,849Deuterium substituted positron emission tomography (PET) imaging agents and their pharmacological application202110,688,200Urea-based prostate specific membrane antigen (PSMA) inhibitors for imaging and therapy202010,253,052HBED-bisphosphonates, radiometal conjugates and their use as theranostic agents20198,840,866'Styrylpyridine derivatives and their use for binding and imaging amyloid plaques'20148,747,809'Single diastereomers of 4-fluoroglutamine and methods of their preparation and use'20148,562,949'Radiolabeled dihydrotetrabenazine derivatives and their use as imaging agents'20138,506,929'Styrylpyridine derivatives and their use for binding and imaging amyloid plaques'2013RE044354'Amyloid plaque aggregation inhibitors and diagnostic imaging agents'2013RE044338'Amyloid plaque aggregation inhibitors and diagnostic imaging agents'20138,465,726'Stilbene derivatives and their use for binding and imaging amyloid plaques'20137,858,072'Stilbene derivatives and their use for binding and imaging amyloid plaques'20107,807,135'Stilbene derivatives and their use for binding and imaging amyloid plaques'20107,759,502'Stilbene derivatives and their use for binding and imaging amyloid plaques'20107,687,052'Styrylpyridine derivatives and their use for binding and imaging amyloid plaques'20107,678,819'Acetylene derivatives and their use for binding and imaging amyloid plaques'20107,425,318'Amyloid plaque aggregation inhibitors and diagnostic imaging agents'20087,297,820'Stilbene derivatives and their use for binding and imaging amyloid plaques'20077,250,525'Stilbene derivatives and their use for binding and imaging amyloid plaques'20077,041,851'Fluorinated phenyl thiophenyl derivatives and their use for imaging serotonin transporters'20066,946,116'Amyloid plaque aggregation inhibitors and diagnostic imaging agents'20056,921,840'SPECT imaging agents for serotonin transporters'20056,864,393'Fluorinated phenyl thiophenyl derivatives and their use for imaging serotonin transporters'20056,696,039'Amyloid plaque aggregation inhibitors and diagnostic imaging agents'20046,241,963'Dopamine and serotonin transporter ligands and imaging agents'20015,980,860'Dopamine and serotonin transporter ligands and imaging agents'19995,744,121'Serotonin (5-HT.sub.1A) receptor ligands and imaging agents'19985,690,906'Dopamine D-3 and serotonin (5-HT.sub.1A) receptor ligands and imaging agents'19975,609,849'Serotonin (5-HT.sub.1A) receptor ligands and imaging agents'19975,446,147'Fluorinated and iodinated dopamine agents'19955,426,189'Dopamine receptor ligands and imaging agents'19955,334,728'Dopamine receptor ligands and imaging agents'19945,320,825'Serotonin reuptake inhibitors for S.P.E.C.T. imaging'19945,278,308'Iodine derivatives of tetrabenazine'19945,186,921'Dopamine receptor ligands and image agents'19935,130,117'Radiohalogenated benzazepine derivatives and method of imaging dopamine receptors therewith'19925,122,361'Dopamine receptor ligands and imaging agents'19925,079,346'Gallium-labelled imaging agents'19925,068,326'Dopamine receptor ligands and imaging agents'19914,980,467'Preparation of radio labeled halogenated compounds'19904,474,746'Diagnostic radiopharmaceuticals for localization in target tissues exhibiting a regional pH shift relative to surrounding tissues'19844,430,319'Radioactive iodine labeled phenolic amines'19844,363,793'Diagnostic radiopharmaceuticals for localization in target tissues exhibiting a regional pH shift relative to surrounding tissues'1982

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1982–1984Based in Amherst, NY, US· patent location history
1990–2014Patents assigned to UNIV PENNSYLVANIA (33)· patent assignee history
1990–2013Based in Wynnewood, PA, US· patent location history
1991–2014Patents assigned to KUNG HANK F (7)· patent assignee history
2010Based in Winnewood, PA, US· patent location history
2013Patents assigned to KUNG MEI-PING (5)· patent assignee history
2013Patents assigned to SKOVRONSKY DANIEL M (3)· patent assignee history
2013–2021Based in Springfield, PA, US· patent location history
2019–2021Patents assigned to FIVE ELEVEN PHARMA INC (4)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
UNIV PENNSYLVANIA331990–2014
KUNG HANK Fself71991–2014
KUNG MEI-PING52013
FIVE ELEVEN PHARMA INC42019–2021
SKOVRONSKY DANIEL M32013
Locations
LocationPatentsSpan
Wynnewood, Pennsylvania, US311990–2013
Springfield, Pennsylvania, US82013–2021
Amherst, New York, US31982–1984
Winnewood, Pennsylvania, US12010